Gianpaolo Reboldi Selected Research

Diabetic Nephropathies (Diabetic Nephropathy)

2/2020	Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
11/2019	Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
4/2011	Optimal therapy in hypertensive subjects with diabetes mellitus.
5/2010	Angiotensin receptor blockers in hypertension. New insights from Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gianpaolo Reboldi Research Topics

Disease

25	Hypertension (High Blood Pressure) 12/2021 - 08/2002
11	Stroke (Strokes) 01/2019 - 08/2005
9	Atrial Fibrillation 01/2022 - 01/2014
8	Heart Failure 01/2022 - 01/2008
7	Cardiovascular Diseases (Cardiovascular Disease) 05/2022 - 01/2004
7	COVID-19 05/2022 - 01/2020
6	Type 2 Diabetes Mellitus (MODY) 06/2020 - 01/2009
6	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019 - 04/2010
5	Hemorrhage 04/2021 - 01/2015
5	Diabetes Mellitus 05/2017 - 11/2009
5	Hypertrophy 03/2015 - 01/2004
5	Myocardial Infarction 08/2012 - 07/2008
4	Diabetic Nephropathies (Diabetic Nephropathy) 02/2020 - 05/2010
4	Infarction (Infarctions) 12/2015 - 01/2010
3	Chronic Renal Insufficiency 05/2022 - 04/2011
3	Infections 07/2021 - 01/2021
3	Coronary Artery Disease (Coronary Atherosclerosis) 10/2020 - 04/2011
3	Thromboembolism 01/2018 - 01/2014
3	Proteinuria 02/2012 - 01/2009
2	Neoplasms (Cancer) 04/2021 - 05/2003
2	Inflammation (Inflammations) 05/2020 - 12/2015
2	Albuminuria 02/2020 - 11/2019
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2018 - 11/2010
2	Systolic Heart Failure 12/2016 - 12/2016
2	Hyperglycemia 12/2015 - 01/2015
2	Embolism (Embolus) 01/2015 - 01/2014
2	Acute Coronary Syndrome 08/2012 - 03/2012
2	Essential Hypertension 01/2004 - 03/2002
1	Hypertensive Crisis 02/2022
1	Venous Thromboembolism 01/2022
1	Pulmonary Arterial Hypertension 12/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Isolated Systolic Hypertension 10/2020
1	Severe Acute Respiratory Syndrome 05/2020
1	Pulmonary Edema 05/2020
1	Mitral Valve Stenosis (Mitral Stenosis) 04/2019
1	Osteoarthritis 11/2018
1	Pain (Aches) 11/2018
1	Tachycardia (Tachyarrhythmias) 01/2017
1	Hypothyroidism 06/2016

Drug/Important Bio-Agent (IBA)

12	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 10/2020 - 08/2005
12	Angiotensin Receptor AntagonistsIBA 10/2020 - 07/2008
9	Pharmaceutical PreparationsIBA 12/2020 - 08/2002
6	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 02/2022 - 08/2005
6	AnticoagulantsIBA 01/2022 - 02/2014
6	aliskiren FDA Link 01/2014 - 01/2008
5	DiureticsIBA 02/2022 - 08/2005
5	Antihypertensive Agents (Antihypertensives)IBA 12/2021 - 02/2006
5	Warfarin (Coumadin)FDA LinkGeneric 01/2018 - 01/2014
4	Biomarkers (Surrogate Marker)IBA 02/2020 - 07/2009
4	Dabigatran FDA Link 01/2018 - 01/2014
4	CholesterolIBA 05/2017 - 01/2004
4	Glucose (Dextrose)FDA LinkGeneric 12/2015 - 02/2006
3	VaccinesIBA 05/2022 - 01/2021
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2010
3	Angiotensin IIIBA 01/2022 - 01/2008
3	Insulin (Novolin)FDA Link 02/2020 - 01/2015
3	Vitamin K FDA Link 01/2018 - 01/2015
3	Ramipril (Altace)FDA LinkGeneric 01/2015 - 06/2010
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2014 - 04/2011
2	Celecoxib (Celebrex)FDA Link 11/2018 - 08/2010
2	CreatinineIBA 01/2018 - 04/2010
2	Natriuretic PeptidesIBA 12/2016 - 12/2016
2	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2016 - 08/2011
2	N(4)-oleylcytosine arabinosideIBA 04/2016 - 01/2014
2	Adrenergic Agents (Adrenergic Drugs)IBA 12/2015 - 01/2015
2	CatecholaminesIBA 12/2015 - 01/2015
2	apixabanIBA 01/2015 - 01/2014
2	Telmisartan (Micardis)FDA Link 01/2015 - 03/2011
2	edoxabanIBA 01/2015 - 01/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2012 - 03/2012
2	HDL CholesterolIBA 03/2009 - 02/2006
1	Vitamin E FDA LinkGeneric 05/2022
1	alpha-Tocopherol FDA Link 05/2022
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022
1	macitentanIBA 12/2021
1	Endothelin Receptor AntagonistsIBA 12/2021
1	aprocitentanIBA 12/2021
1	Dihydrotachysterol (AT 10)IBA 07/2021
1	Uric Acid (Urate)IBA 02/2021
1	ThiazidesIBA 10/2020
1	Troponin T (Troponin T1)IBA 01/2019
1	Troponin IIBA 01/2019
1	Amlodipine (Norvasc)FDA LinkGeneric 11/2018
1	TabletsIBA 11/2018
1	fimasartanIBA 05/2018
1	PotassiumIBA 01/2017
1	omega-Chloroacetophenone (Mace)IBA 01/2017
1	SodiumIBA 01/2017
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 12/2016
1	Thyroxine (Levothyroxine)FDA LinkGeneric 06/2016

Therapy/Procedure

13	Therapeutics 05/2022 - 03/2002
2	Drug Therapy (Chemotherapy) 02/2022 - 07/2009
2	Catheter Ablation 04/2021 - 01/2018
2	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2020 - 01/2018
1	Secondary Prevention 05/2022
1	Artificial Kidneys 05/2022
1	Renal Dialysis (Hemodialysis) 01/2021